Gene-to-protein manufacturing including custom enzymes, recombinant antibodies, and proteins. 

Our protein production capabilities range from parallel screening of several constructs through process development optimization, to "scale-up" manufacturing. Every project starts by defining project goals, including transferring existing protocols or developing a new method.

With experience producing thousands of proteins, we identify potential risks and engineer a solution to meet your required specifications. Responsiveness, technical excellence, and strong project management form the foundation of every strong partnership. It’s our goal to embody those qualities and earn your trust every step of the way.

We develop strategies in E. coli, insect and mammalian expression systems to produce recombinant proteins specific for your application.

As a biological CRO company, Biologics International Corp (hereinafter referred to as BIC) has long devoted itself to the R&D of technologies related to recombinant protein and antibody. We keep assisting our clients from scientific research institutes and pharmaceutical enterprises in designing and developing their project schemes about discovery and verification of unknown targets, small-scaled and massive preparation of known protein/antibody, high-affinity antibody screening and process optimization. Continuous efforts have been made by us to improve the technical capacity and infrastructure construction in such fields as recombinant protein, traditional antibody, and recombinant antibody. Based on the increasingly improved technical capacity, we can provide and will launch more zero-risk services for the benefit of you in both capital and time cost.